ANI Pharmaceuticals Reports Full Year 2016 Results and Fourth Quarter Results and Provides 2017 Guidance

Go back to ANI Pharmaceuticals Reports Full Year 2016 Results and Fourth Quarter Results and Provides 2017 Guidance

ANI Pharma (ANIP) Reports Q4 EPS of 84c

March 2, 2017 8:34 AM EST

ANI Pharma (NASDAQ: ANIP) reported Q4 EPS of $0.84, may not compare to the analyst estimate of $1.09. Revenue for the quarter came in at $38.2 million versus the consensus estimate of $40.71 million.

GUIDANCE:

ANI Pharma sees FY2017 EPS of... More